Prostate Cancer Foundation
Philip Kantoff is a distinguished medical professional currently serving as Co-Founder and Chief Executive Officer of Convergent Therapeutics, Inc. Since November 2015, Philip Kantoff has held the position of Jerome and Nancy Kohlberg Professor Emeritus at Harvard Medical School. In addition to these roles, Philip Kantoff serves on the boards of the Prostate Cancer Foundation, ESSA Pharma, and Context Therapeutics. Prior to these appointments, Philip Kantoff was Chairman of Medicine at Memorial Sloan Kettering Cancer Center from November 2015 to June 2021 and Division Head of Solid Tumor Oncology at Dana-Farber Cancer Institute from January 1991 to November 2015. Philip Kantoff earned a Doctor of Medicine degree in Medical Oncology from The Warren Alpert Medical School of Brown University after completing education at Brown University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) was founded in 1993 to find better treatments and a cure for recurrent prostate cancer. Through its unique model for soliciting and selecting promising research programs and rapid deployment of resources, the PCF has funded more than 1,500 programs at nearly 200 research centers in 20 countries around the world. As the world’s leading philanthropic organization for funding prostate-cancer research, the PCF is now a foundation without borders. Its advocacy for increased government and private support of prostate cancer programs has helped build a global research enterprise of nearly $10 billion.